Correspondence
Risk of hepatitis B reactivation associated with treatment against SARS-CoV-2 (COVID-19) with corticosteroids
Riesgo de reactivación de la hepatitis B asociado al tratamiento con corticoides frente a SARS-CoV-2 (COVID-19)
J. Varona Pérez
, J.M. Rodriguez Chinesta
Servicio de Medicina Interna, Hospital Universitario de Cruces. Barakado, Vizcaya, Spain
Read
1381
Timeswas read the article
191
Total PDF
1190
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 0 | 1 | 1 |
| 2025 5 | 44 | 2 | 46 |
| 2025 4 | 25 | 0 | 25 |
| 2025 3 | 30 | 3 | 33 |
| 2025 2 | 22 | 0 | 22 |
| 2025 1 | 28 | 0 | 28 |
| 2024 12 | 19 | 0 | 19 |
| 2024 11 | 19 | 1 | 20 |
| 2024 10 | 24 | 0 | 24 |
| 2024 9 | 11 | 0 | 11 |
| 2024 8 | 14 | 0 | 14 |
| 2024 7 | 10 | 2 | 12 |
| 2024 6 | 10 | 3 | 13 |
| 2024 5 | 15 | 0 | 15 |
| 2024 4 | 13 | 0 | 13 |
| 2024 3 | 12 | 0 | 12 |
| 2024 2 | 5 | 0 | 5 |
| 2024 1 | 10 | 0 | 10 |
| 2023 12 | 13 | 0 | 13 |
| 2023 11 | 30 | 0 | 30 |
| 2023 10 | 24 | 0 | 24 |
| 2023 9 | 21 | 0 | 21 |
| 2023 8 | 19 | 1 | 20 |
| 2023 7 | 24 | 1 | 25 |
| 2023 6 | 21 | 0 | 21 |
| 2023 5 | 28 | 3 | 31 |
| 2023 4 | 26 | 0 | 26 |
| 2023 3 | 25 | 4 | 29 |
| 2023 2 | 22 | 6 | 28 |
| 2023 1 | 26 | 3 | 29 |
| 2022 12 | 31 | 3 | 34 |
| 2022 11 | 35 | 3 | 38 |
| 2022 10 | 27 | 7 | 34 |
| 2022 9 | 17 | 2 | 19 |
| 2022 8 | 22 | 5 | 27 |
| 2022 7 | 32 | 4 | 36 |
| 2022 6 | 20 | 3 | 23 |
| 2022 5 | 25 | 2 | 27 |
| 2022 4 | 32 | 5 | 37 |
| 2022 3 | 31 | 6 | 37 |
| 2022 2 | 29 | 7 | 36 |
| 2022 1 | 38 | 9 | 47 |
| 2021 12 | 45 | 7 | 52 |
| 2021 11 | 19 | 2 | 21 |
| 2021 10 | 10 | 4 | 14 |
| 2021 9 | 24 | 4 | 28 |
| 2021 8 | 37 | 7 | 44 |
| 2021 7 | 20 | 10 | 30 |
| 2021 6 | 18 | 8 | 26 |
| 2021 5 | 14 | 8 | 22 |
| 2021 4 | 19 | 4 | 23 |
| 2021 3 | 5 | 2 | 7 |
| 2021 2 | 3 | 3 | 6 |
| 2021 1 | 4 | 12 | 16 |
| 2020 12 | 9 | 10 | 19 |
| 2020 11 | 13 | 5 | 18 |
| 2020 10 | 3 | 2 | 5 |
| 2020 9 | 3 | 5 | 8 |
| 2020 8 | 9 | 7 | 16 |
| 2020 7 | 6 | 5 | 11 |
Show all
